A gene, designated khe, that encodes a haemolysin of Klebsiella pneumoniae CMC-1 has been cloned and sequenced. When expressed in Escherichia coli, a unique peptide of approximately 20kDa was identified. Nucleotide sequence analysis predicted a single open reading frame (ORF) of 486bp encoding a 162 amino acid polypeptide with an estimated pI of 6.77. No extensive sequence homology could be identified between khe and any reported sequence at either the nucleotide or amino acid level. Furthermore, DNA hybridizations under high stringency conditions failed to show any cross hybridizations to several bacteria including K. oxytoca, K. planticola, K. terrigena and K. ornithinolytica. These data indicate that we have cloned a unique gene, which is highly conserved among tested K. pneumoniae isolates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1006/mpat.2002.0499 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Isolation and characterization of DNA aptamers against the HlyE antigen of Salmonella Typhi.
Sci Rep
November 2024
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Kubang Kerian, Kelantan, 16150, Malaysia.
Article Synopsis
Isothermal recombinase polymerase amplification and silver nanoparticle assay: a sustainable approach for ultrasensitive detection of .
Anal Methods
October 2024
Department of Biological Sciences, BITS Pilani Hyderabad Campus, Telangana State 500078, India.
Our study addresses the urgent need for effective detection of , a recognized threat by the World Health Organization (WHO). Current challenges in managing infections include the lack of rapid and affordable detection tools, particularly in resource-limited point-of-care (POC) settings. To tackle this, we developed an innovative molecular detection pipeline combining three POC-compatible methods.
View Article and Find Full Text PDFA rational designed multi-epitope vaccine elicited robust protective efficacy against Klebsiella pneumoniae lung infection.
Biomed Pharmacother
May 2024
National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China. Electronic address:
Article Synopsis
Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacterales: a prospective multicentre study.
J Antimicrob Chemother
March 2024
Department of Medical Sciences, Section of Infectious Diseases, Uppsala University, Uppsala, Sweden.
Objectives: Treatment options for urinary tract infections (UTIs) caused by ESBL-producing Enterobacterales are limited. Moreover, evidence to support therapeutic decisions is lacking. This study assessed current treatment strategies and patient and pathogen characteristics in relation to clinical and microbiological outcomes.
View Article and Find Full Text PDFMonitoring the battleground: exploring antimicrobial resistance and virulence factors in wound bacterial isolates.
Access Microbiol
November 2023
Department of Medical Laboratory Sciences, School of Health Sciences, South Eastern Kenya University, Kitui, Kenya.
Antibiotic resistance poses a grave global public health threat, exacerbated by widespread and often inappropriate antibiotic usage. Vigilant surveillance of antibiotic utilization and emergence of antimicrobial resistance (AMR) is essential. Of particular concern in the era of AMR is the persistent issue of chronic wound infections.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!